To study the potential anti-tumor function of 22B12 mAb in vivo, we used a xenograft mouse model of CD160-TM+ TNBC tumor in the SCID mouse, known to retain partially functional NK cells and fully functional macrophages [43]. This evidence concerns the gene CD160 and neoplasm.